The patient gene therapy journey: Findings from qualitative interviews with trial participants at one UK haemophilia centre
Gene therapy for haemophilia is in late-stage clinical development and has the potential to become a therapeutic option in clinical practice.
Main Authors: | Aradom Elsa, Gomez Keith |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-05-01
|
Series: | The Journal of Haemophilia Practice |
Subjects: | |
Online Access: | https://doi.org/10.17225/jhp00174 |
Similar Items
-
Experience of switching to NovoEight: views of people with haemophilia
by: Pollard Debra, et al.
Published: (2020-06-01) -
Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia
by: Chuansumrit A, et al.
Published: (2022-10-01) -
Educational needs of patients, families, and healthcare professionals to support the patient journey in haemophilia gene therapy in the UK
by: Sara Boyce, et al.
Published: (2023-11-01) -
Self-reported activity of Swedish persons with haemophilia: Change over 2.5 years
by: Elisabeth Brodin, et al.
Published: (2018-06-01) -
Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status
by: Amir Abbasnezhad, et al.
Published: (2020-01-01)